Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
HIV-infected patients have a significantly greater risk of cardiovascular disease. Several markers including osteoprotegerin have been shown to be involved in the development and progression of atherosclerosis. We investigated the relationship between T-cell phenotype, osteoprotegerin, and atheroscl...
Saved in:
Main Authors: | Alessandra D’Abramo, Maria Antonella Zingaropoli, Alessandra Oliva, Claudia D’Agostino, Samir Al Moghazi, Giulia De Luca, Marco Iannetta, Claudio Maria Mastroianni, Vincenzo Vullo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/192594 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus
by: Irene Lambrinoudaki, et al.
Published: (2013-01-01) -
Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01) -
Immunosenescence of Polymorphonuclear Neutrophils
by: Inga Wessels, et al.
Published: (2010-01-01) -
Interleukin-7 and Immunosenescence
by: Vanloan Nguyen, et al.
Published: (2017-01-01) -
For a design transition – Green composition and design for the contemporary city
by: Claudia Pirina, et al.
Published: (2024-06-01)